Zinodap M 10mg/500mg Tablet ER
Marketer
Wockhardt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Zinodap M 10mg/500mg Tablet ER
Diabexe Duo 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This dual-action formulation effectively regulates elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Diabexe Duo 10mg/500mg ER tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation should only occur under medical supervision, as abrupt cessation may lead to dangerously high blood sugar, potentially causing kidney damage or vision loss. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, physical activity, and weight management as advised by your doctor. Commonly reported side effects include sore throat, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital yeast infections may occur; maintaining good hygiene is recommended to minimize this risk. Prior to initiating treatment, discuss any existing kidney or liver conditions, urinary tract infections, or diuretic use with your physician. Pregnant or lactating women should seek medical counsel. Limit alcohol consumption as it might exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Zinodap M 10mg/500mg Tablet ER
No information provided. Please provide the text you wish to be rewritten.
Uses of Zinodap M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Zinodap M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Zinodap M 10mg/500mg Extended-Release tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Zinodap M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Zinodap M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zinodap M 10mg/500mg Extended-Release tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Zinodap M 10mg/500mg Tablet ER works:
The extended-release tablet, Zinodap M 10mg/500mg, combines the antidiabetic agents dapagliflozin and metformin. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action synergistically improves glycemic management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Zinodap M 10mg/500mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Zinodap M 10mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Zinodap M 10mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Zinodap M 10mg/500mg Extended-Release Tablets. Dosage modification of Zinodap M 10mg/500mg Extended-Release Tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using extended-release Zinodap M 10mg/500mg tablets. Dosage modification of Zinodap M 10mg/500mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Zinodap M 10mg/500mg Tablet ER :
Should you forget to take a Zinodap M 10mg/500mg Extended-Release tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zinodap M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |






